Fase III |
A controlled, open-label post-authorisation efficacy and safety study in... |
Nefrología |
Si |
Fase III |
A multicenter, open-label study to investigate the effectiveness and safety of AOP... |
Cardiología Pediátrica |
No |
Fase III |
A multi-center, open-label, uncontrolled, single-arm, extension study to determine... |
Neurología |
Si |
Fase III |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group... |
Neurología |
Si |
Fase II |
A Multicentre Controlled Open Randomized Clinical Trial to evaluate the efficacy... |
Infecciosas |
No |
Fase II |
A phase 2, 24-week, adaptive, open label, sequential cohort trial to evaluate the... |
Nefrología |
Si |
Fase II |
A phase 2, multicenter, open-label study to assess appropriate dosing and to... |
Oncohematología Pediátrica |
Si |
Fase II |
A Phase 2, Open-Label, Single-Arm Study of Pamiparib (BGB-290) for the Treatment of... |
Sin clasificar |
No |
Fase II |
A Phase 2 Open-Label Study of Continuation Treatment With Combination Pyrimidine... |
Pediatría General y Especialidades |
Si |
Fase II |
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter, Dose-... |
Sin clasificar |
Si |
Fase II |
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate theSafety, Efficacy... |
Nefrología |
Si |
Fase III |
A phase 2/3, randomized, open-label, parallel group, 2-arm, multicenter study... |
Medicina Interna |
Si |
Fase III |
A Phase 2/3 Single-Arm, Open-Label Study to Evaluate the Safety, Tolerability,... |
Pediatría General y Especialidades |
Si |
Fase III |
A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445... |
Neumología |
Si |
Fase III |
A Phase 3, Open-label Study Evaluating the Long-term Safety of VX-445 Combination... |
Neumología |
Si |
Fase III |
A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate a Switch to... |
Infecciosas |
Si |
Fase III |
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to... |
Neumología |
No |
Fase III |
A Phase 3 Randomized, Open-Label, Multicenter Study Comparing Zanubrutinib (BGB-3111... |
Pediatría General y Especialidades |
Si |
Fase III |
A Phase 3 Study of the Efficacy and Safety of Lixivaptan in Participants with... |
Nefrología |
No |
Fase III |
A Phase 3b, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Elexacaftor/... |
Obstetricia |
Si |
Fase III |
A PHASE IIIb MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY... |
Neuroinmunología |
Si |
Fase III |
A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the... |
Cardiología |
Si |
Fase III |
A Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for... |
Nefrología |
Si |
Fase II |
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-... |
Reumatología |
Si |